Onconetix
Manufacturing · Ohio, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
201 E 5th St Ste 190, Cincinnati, Ohio, ...Phone Number
(513) 620-4101Website
www.onconetix.comRevenue
<$5 MillionStock Symbol
ONCOIndustry
About Onconetix
Onconetix, Inc. is a commercial-stage biotechnology company headquartered in Cincinnati, Ohio, with operations in Zurich, Switzerland through its subsidiary Proteomedix AG. The company develops and commercializes diagnostic and therapeutic solutions for men’s health and oncology, particularly prostate cancer and benign prostatic hyperplasia (BPH). Its portfolio includes Proclarix, a CE-IVD certified blood test for prostate cancer detection, and Entadfi, an FDA-approved oral therapy for BPH. Onconetix also pursues licensing partnerships and clinical validation studies to expand its technologies in the U.S. and European markets.Explore more
SIC Code 28,283NAICS Code 32,325Ticker NASDAQ: ONCOShow moreOnconetix Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Onconetix
Sign Up For FreeTo access detailed company insights
Onconetix, Inc. is a commercial-stage biotechnology company headquartered in Cincinnati, Ohio, with operations in Zurich, Switzerland through its subsidiary Proteomedix AG. The company develops and commercializes diagnostic and therapeutic solutions for men’s health and oncology, particularly prostate cancer and benign prostatic hyperplasia (BPH).... Read More
